Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
15-year-old boy hospitalized after nearly drowning at Raleigh pool on Schaub Drive
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
110.32
+0.39 (+0.35%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
28
29
Next >
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
April 28, 2023
Microsoft, Meta, Cloudflare and Crocs were among the many big movers.
Via
Investor's Business Daily
Is This Big Pharma Stock a Buy for Dividend Investors?
April 27, 2023
The Swiss pharmaceutical giant possesses a tremendous product pipeline.
Via
The Motley Fool
Rare Blood Disorder Treatment Breakthrough: Novartis' Candidate Improves Hemoglobin To Near-Normal Levels
April 26, 2023
Novartis AG (NYSE: NVS) released detailed
Via
Benzinga
After Q1 Review, Novartis Narrows R&D Pipeline To Prioritize High-Value Transformative Medicines
April 25, 2023
In its Q1 FY23 earnings release, Novartis AG (NYSE: NVS) announced cutting its pipeline by around 10% as CEO Vas Narasimhan's campaign to turn it into a "pure-play" drugmaker goes full steam.
Via
Benzinga
Why Novartis Stock Is Trading Higher Today
April 25, 2023
Via
Benzinga
Earnings Preview: Novartis
April 24, 2023
Via
Benzinga
New York Rep. Daniel Goldman Bought Over $50K Worth of Novartis Stock: Here's What You Should Know
April 18, 2023
Via
Benzinga
Novartis Extends Breakout As Three Key Drivers Lead To A Beat-And-Raise
April 25, 2023
Novartis stock popped on its guidance boost early Tuesday after the company beat first-quarter expectations.
Via
Investor's Business Daily
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
All three companies have therapies with strong sales potential.
Via
The Motley Fool
Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up Five Years With Kesimpta Treatment
April 20, 2023
Via
Benzinga
Why Shares of Legend Biotech Jumped Wednesday
April 19, 2023
A leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt.
Via
The Motley Fool
2 Best Biotech Stocks to Buy for the Long Haul
April 17, 2023
These two are among the largest pharma companies in the world.
Via
The Motley Fool
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.
Via
InvestorPlace
Novartis Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 13, 2023
Via
Benzinga
FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy
March 27, 2023
Via
Benzinga
Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says
April 13, 2023
Via
Benzinga
Alzheimer's Disease Largely Remains A Mystery, With A Lack Of Highly Effective Treatments — Could Regulatory T-Cells (Tregs) Be The Answer?
April 13, 2023
In many ways, Alzheimer's disease (AD) remains a mystery. Most common in those over 65, AD is the most common form of dementia, but its exact causes remain unclear, and treatments are unable to halt or...
Via
Benzinga
Trillions In Biotech Stock Gains Trace Back To This Financier
April 13, 2023
Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.
Via
Investor's Business Daily
Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move
April 10, 2023
Via
Benzinga
Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket
April 10, 2023
Shares are closing in on a buy point out of a consolidation.
Via
Investor's Business Daily
Cryoport Supports Clinical Trials And Commercial Therapies Across The High-Growth BioTech Industry: Is Its Current Stock Price An Opportunity?
April 10, 2023
The global biotechnology industry was worth $859 billion in 2022, and it is predicted to reach $1.6 trillion by 2030, growing at a compound annual growth rate (CAGR) of 8.7% over the forecast period.
Via
Benzinga
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative'
April 07, 2023
Rocket Pharma (NASDAQ: RCKT) CEO Gaurav Shah is on a mission to "change the narrative" when it comes to rare diseases.
Via
Benzinga
7 Very Undervalued Penny Stocks to Buy in April 2023
April 06, 2023
Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option.
Via
InvestorPlace
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat
April 05, 2023
Millions of people are scrambling to get their ADHD medication. Here's why.
Via
Investor's Business Daily
Stock Market Rallies On Micron, Alibaba, Lululemon, Ebbing Bank Fears: Weekly Review
March 31, 2023
The stock market rallied on ebbing bank fears and positive news from Micron, Alibaba and Lululemon Athletica.
Via
Investor's Business Daily
What Bear Market? These 2 Winning Stocks Are Still Worth Buying.
March 30, 2023
These two pharma stocks are rock-solid picks in any kind of market.
Via
The Motley Fool
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 27, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
Via
Benzinga
Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories
March 27, 2023
Benzinga
Via
Benzinga
Novartis Surges As It Goes After Eli Lilly's Second Biggest Moneymaker
March 27, 2023
The battle in early-stage breast cancer is heating up as Novartis enters the ring.
Via
Investor's Business Daily
Why Novartis Shares Are Trading Higher Premarket Today
March 27, 2023
Novartis AG (NYSE: NVS) shares are trading higher in the premarket session after its breast cancer drug showed clinical benefit in early-stage breast cancer.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.